David G. Barrett

1.3k total citations
50 papers, 1.0k citations indexed

About

David G. Barrett is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, David G. Barrett has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Organic Chemistry and 13 papers in Pharmacology. Recurrent topics in David G. Barrett's work include Bone Metabolism and Diseases (8 papers), Natural product bioactivities and synthesis (6 papers) and Cancer therapeutics and mechanisms (6 papers). David G. Barrett is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Natural product bioactivities and synthesis (6 papers) and Cancer therapeutics and mechanisms (6 papers). David G. Barrett collaborates with scholars based in United States, Japan and Germany. David G. Barrett's co-authors include Henning Hopf, Alexander M. Efanov, Samuel H. Gellman, Samreen K. Syed, Lisa S. Beavers, David N. Deaton, James Ficorilli, Krister Bokvist, Thomas B. Farb and Lois L. Wright and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Chemical Communications.

In The Last Decade

David G. Barrett

50 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Barrett United States 17 483 366 176 139 111 50 1.0k
Henrianna Pang Canada 20 518 1.1× 275 0.8× 109 0.6× 236 1.7× 65 0.6× 26 1.6k
James V. Heck United States 19 614 1.3× 483 1.3× 232 1.3× 113 0.8× 157 1.4× 30 1.6k
Tuomo Laitinen Finland 26 970 2.0× 354 1.0× 278 1.6× 98 0.7× 90 0.8× 90 1.8k
Gino Salituro United States 20 803 1.7× 392 1.1× 337 1.9× 194 1.4× 282 2.5× 46 1.6k
Lawrence F. Colwell United States 19 555 1.1× 398 1.1× 106 0.6× 30 0.2× 108 1.0× 33 1.2k
Andrew J. Peat United States 20 705 1.5× 683 1.9× 54 0.3× 233 1.7× 232 2.1× 36 1.5k
Tesfaye Biftu United States 23 596 1.2× 505 1.4× 146 0.8× 43 0.3× 172 1.5× 53 1.5k
Scott E. Lazerwith United States 11 362 0.7× 248 0.7× 465 2.6× 98 0.7× 64 0.6× 14 1.1k
Teruki Yoshimura Japan 22 460 1.0× 129 0.4× 67 0.4× 79 0.6× 45 0.4× 73 1.1k
Giovanni Grazioso Italy 23 737 1.5× 336 0.9× 117 0.7× 133 1.0× 21 0.2× 73 1.2k

Countries citing papers authored by David G. Barrett

Since Specialization
Citations

This map shows the geographic impact of David G. Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Barrett more than expected).

Fields of papers citing papers by David G. Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Barrett. The network helps show where David G. Barrett may publish in the future.

Co-authorship network of co-authors of David G. Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Barrett. A scholar is included among the top collaborators of David G. Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Barrett. David G. Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qi, Haitao Hu, Juan F. Espinosa, et al.. (2022). Activation of the human insulin receptor by non-insulin-related peptides. Nature Communications. 13(1). 5695–5695. 15 indexed citations
2.
Song, Luyan, David G. Barrett, Karen L. Cox, et al.. (2020). A High-Throughput Assay for the Pancreatic Islet Beta-Cell Potassium Channel: Use in the Pharmacological Characterization of Insulin Secretagogues Identified from Phenotypic Screening. Assay and Drug Development Technologies. 19(1). 27–37. 2 indexed citations
3.
Ishida, Junya, et al.. (2020). Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459. Bioorganic & Medicinal Chemistry Letters. 30(18). 127423–127423. 1 indexed citations
4.
Yoshimura, Seiji, et al.. (2020). Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV. Bioorganic & Medicinal Chemistry Letters. 30(16). 127308–127308. 2 indexed citations
5.
Shaghafi, Michael B., David G. Barrett, Francis S. Willard, & Larry E. Overman. (2014). The insulin secretory action of novel polycyclic guanidines: Discovery through open innovation phenotypic screening, and exploration of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 24(4). 1031–1036. 7 indexed citations
6.
Tomishima, Masaki, et al.. (2009). FR290581, a novel sordarin derivative: Synthesis and antifungal activity. Bioorganic & Medicinal Chemistry Letters. 19(5). 1465–1468. 30 indexed citations
7.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2006). Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(6). 1735–1739. 16 indexed citations
8.
Barrett, David G., David N. Deaton, Robert T. Gampe, et al.. (2005). Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?. Bioorganic & Medicinal Chemistry Letters. 16(4). 978–983. 12 indexed citations
9.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2005). A structural screening approach to ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(9). 2209–2213. 12 indexed citations
10.
Barrett, David G., David N. Deaton, Anne M. Hassell, et al.. (2005). Acyclic cyanamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(12). 3039–3043. 24 indexed citations
11.
Efanov, Alexander M., David G. Barrett, Martin Brenner, et al.. (2005). A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte Function. Endocrinology. 146(9). 3696–3701. 106 indexed citations
12.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions. Bioorganic & Medicinal Chemistry Letters. 14(19). 4897–4902. 24 indexed citations
13.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(10). 2543–2546. 10 indexed citations
14.
Barrett, David G.. (2002). From natural products to clinically useful antifungals. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(2-3). 224–233. 104 indexed citations
15.
Barrett, David G., et al.. (2001). Novel Amidine Conjugates of the Ornithine Moiety of the Macrocyclic Antifungal Lipopeptidolactone FR901469.. The Journal of Antibiotics. 54(10). 844–847. 3 indexed citations
16.
Uehling, David, David N. Deaton, Elizabeth E. Sugg, et al.. (2001). Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres. Journal of Medicinal Chemistry. 45(3). 567–583. 48 indexed citations
17.
Barrett, David G., Keiji Matsuda, Kenichi Washizuka, et al.. (1999). Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems. Part III:. Bioorganic & Medicinal Chemistry. 7(8). 1665–1682. 5 indexed citations
18.
Matsuda, Keiji, David G. Barrett, Kouji Hattori, et al.. (1997). Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems—I. 2-alkoxymethyl derivatives. Bioorganic & Medicinal Chemistry. 5(11). 2069–2087. 9 indexed citations
19.
Barrett, David G., Kohji Kawabata, Nobuyoshi Yasuda, et al.. (1997). Studies on .BETA.-Lactam Antibiotics. Synthesis and Antibacterial Activity of Novel C-3 Alkyne-substituted Cephalosporins.. The Journal of Antibiotics. 50(1). 100–102. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrianna Pang Breakdown of academic impact, for papers by James V. Heck Breakdown of academic impact, for papers by Tuomo Laitinen Breakdown of academic impact, for papers by Gino Salituro Breakdown of academic impact, for papers by Lawrence F. Colwell Breakdown of academic impact, for papers by Andrew J. Peat Breakdown of academic impact, for papers by Tesfaye Biftu Breakdown of academic impact, for papers by Scott E. Lazerwith Breakdown of academic impact, for papers by Teruki Yoshimura Breakdown of academic impact, for papers by Giovanni Grazioso
Rankless by CCL
2026